Galmed Pharmaceuticals Ltd. (GLMD) — Earnings Call Analysis & IR Page

Galmed Pharmaceuticals Ltd is a Healthcare company operating in Biotechnology with a $4.9M market cap.

Most recent earnings call: Q4 FY21 on May 2, 2022.

4 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

IR URL not yet extracted for GLMD.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 4 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GLMD.

$ curl https://api.spokenalpha.com/v1/companies/GLMD

Get an API key API docs

FAQ

Frequently asked about GLMD

Where can I find Galmed Pharmaceuticals Ltd.'s (GLMD) earnings call transcripts?

Spoken Alpha indexes GLMD's earnings call transcripts at https://spokenalpha.com/companies/GLMD. Each call links to attributed speakers and parsed analyst Q&A.

When was Galmed Pharmaceuticals Ltd.'s most recent earnings call?

Galmed Pharmaceuticals Ltd. (GLMD) held its most recent earnings call on 2022-05-02, covering fiscal Q4 2021.

What sector is GLMD in?

Galmed Pharmaceuticals Ltd. (GLMD) operates in the Healthcare sector (Biotechnology industry).

Overview